Ignite Creation Date:
2025-12-24 @ 10:08 PM
Ignite Modification Date:
2026-01-04 @ 4:55 AM
Study NCT ID:
NCT02167035
Status:
COMPLETED
Last Update Posted:
2018-10-24
First Post:
2014-06-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Comparison of Combigan Two Times Daily (BID) Versus Simbrinza Three Times Daily (TID)
Sponsor:
Cornerstone Health Care, PA
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
TEP001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |